BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/12/2022 8:42:29 AM | Browse: 1073 | Download: 2094
Publication Name World Journal of Gastroenterology
Manuscript ID 73205
Country United States
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Novel drug delivery systems for inflammatory bowel disease
Manuscript Source Invited Manuscript
All Author List Farah Yasmin, Hala Najeeb, Shehryar Shaikh, Muhammad Hasanain, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Syedadeel Hasan and Salim Surani
ORCID
Author(s) ORCID Number
Farah Yasmin http://orcid.org/0000-0002-5264-6140
Hala Najeeb http://orcid.org/0000-0001-7075-4674
Shehryar Shaikh http://orcid.org/0000-0003-2354-4994
Muhammad Hasanain http://orcid.org/0000-0001-9214-7840
Unaiza Naeem http://orcid.org/0000-0002-0455-7864
Abdul Moeed http://orcid.org/0000-0003-4429-1391
Thoyaja Koritala http://orcid.org/0000-0002-1020-9882
Syedadeel Hasan http://orcid.org/0000-0002-8484-0319
Salim Surani http://orcid.org/0000-0001-7105-4266
Funding Agency and Grant Number
Corresponding Author Salim Surani, FACP, FCCP, MD, MSc, Doctor, Doctor, Professor, Medicine, Texas A&M University, 400 Bizzell St, College Station,, College Station, Texas 77843, United States. srsurani@hotmail.com
Key Words Inflammation; Inflammatory bowel diseases; Colitis; Ulcerative; Crohn’s disease; Drug delivery systems; Drug carrier
Core Tip Current literature on novel drug delivery systems is extensive. However, limited content is available that focuses on the novel drug delivery strategies, focally the enteric-coated microneedles pills and biological drug delivery systems. In our review, we discuss multiple novel approaches comprehensively, after outlining the disease course in inflammatory bowel diseases (IBD) and how the conventional routes of drug administrations are deficient in addressing some aspects of disease treatment. We specify that novel carrier systems can be considered for targeting inflamed sites in IBD and discuss the implications of choosing such routes.
Publish Date 2022-05-12 08:42
Citation Yasmin F, Najeeb H, Shaikh S, Hasanain M, Naeem U, Moeed A, Koritala T, Hasan S, Surani S. Novel drug delivery systems for Inflammatory bowel disease. World J Gastroenterol 2022; 28(18): 1922-1933
URL https://www.wjgnet.com/1007-9327/full/v28/i18/1922.htm
DOI https://dx.doi.org/10.3748/wjg.v28.i18.1922
Full Article (PDF) WJG-28-1922.pdf
Full Article (Word) WJG-28-1922.docx